Type 2 Diabetes Mellitus (T2DM) is a massive topic for the UKMLA AKT, and NICE guidelines (NG28) are your absolute bible here. Let's break this down into the targets, the management steps, and the complications you need to look out for.

1. HbA1c Targets

NICE is very specific about these targets based on the patient's treatment:

• Lifestyle + Single Drug (not associated with hypoglycemia, e.g., Metformin): Target is 48 mmol/mol (6.5%).
• Drug associated with hypoglycemia (e.g., Sulfonylureas): Target is 53 mmol/mol (7.0%).
• If HbA1c rises to 58 mmol/mol (7.5%): This is the trigger to intensify treatment and aim for a target of 53 mmol/mol (7.0%).

2. NICE Treatment Algorithm

The management of T2DM has shifted recently to prioritize cardiovascular and renal protection.

First-line:

• Standard: Metformin (modified-release if GI side effects occur).
• High CV Risk: If the patient has Chronic Heart Failure, established Atherosclerotic CVD, or a high QRISK3 score (≥10%), you should start an SGLT2 inhibitor (like Dapagliflozin) in addition to Metformin once the Metformin dose is titrated.

Second-line (Dual Therapy): If HbA1c rises to 58 mmol/mol, add a second agent:

• SGLT2 inhibitor
• Dipeptidyl peptidase-4 (DPP-4) inhibitor (the "gliptins")
• Pioglitazone
• Sulfonylurea (e.g., Gliclazide)

Third-line (Triple Therapy):

• Metformin + two of the above, or start Insulin.

GLP-1 Mimetics (e.g., Semaglutide): Usually reserved for triple therapy when BMI is ≥35 kg/m² (or <35 if insulin has significant occupational implications or weight loss would benefit other comorbidities).

3. Complications

We generally split these into Microvascular and Macrovascular:

I've put together a flowchart of the NICE treatment algorithm to help you visualize those steps more clearly.

The flowchart above summarizes the NICE NG28 pathway, highlighting the crucial decision point regarding cardiovascular risk.

To help you lock this in for your AKT prep, I've found some high-yield lessons and flashcards specifically focused on these guidelines and the complications of diabetes.

I've pulled up those high-yield lessons for you to dive deeper into the pharmacology and pathophysiology.

Since the flashcard search was a bit too specific, let me try a broader search for you. It's really helpful to have those quick-fire facts on the tips of your fingers for the AKT.

That's a solid set of flashcards to get you started!

One last thing for your AKT prep: remember that for the UKMLA, you'll often be asked about the annual review for T2DM patients. This includes:

• HbA1c (every 3-6 months until stable, then 6-monthly).
• Renal function: Check eGFR and Urinary Albumin:Creatinine Ratio (ACR).
• Foot check: Assessing for neuropathy (monofilament test) and peripheral vascular disease.
• Retinopathy screening: Digital photography of the retina.
• Blood pressure & Lipids: Aiming for <140/90 mmHg (or <130/80 if there's kidney/eye/cerebrovascular damage) and starting a statin (usually Atorvastatin 20mg) for primary prevention if QRISK3 is high.

Is there a specific part of the algorithm or a complication you'd like to dive into more? Or maybe you're ready for a quick quiz to test your knowledge?